2026-10-06T01:35:26.000Z · 17 days ago Versigent price target lowered to $58 from $59 at Goldman Sachs
2026-08-10T12:20:52.000Z · 2 months ago Versigent price target raised to $65 from $60 at Evercore ISI
2026-08-05T14:18:48.000Z · 2 months ago Versigent downgraded to Equal-Weight from Outperform at Fox Advisors
2026-08-05T13:49:41.000Z · 2 months ago Versigent price target raised to $54 from $50 at Deutsche Bank
2026-08-05T13:44:51.000Z · 2 months ago Versigent price target raised to $59 from $48 at Goldman Sachs
2026-08-05T01:15:16.000Z · 2 months ago Versigent upgraded to Outperform from Sector Perform at RBC Capital
2026-08-04T11:17:25.000Z · 2 months ago Versigent raises 2026 revenue view to $9.4B-$9.6B from $9.1B-$9.4B
May 19, 2026, 9:00 AM EDT · 5 months ago Versigent Announces Participation in June Investor Conferences
2026-05-18T12:50:32.000Z · 5 months ago Versigent price target raised to $60 from $55 at Evercore ISI
Apr 21, 2026, 2:03 PM EDT · 6 months ago Versigent Announces First Quarter 2026 Earnings Call and Participation in May Investor Conferences